Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of Lebrikizumab in adults with mild to moderate asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 3 | Status: COMPLETED